procedure • Malaysia

Subcutaneous Infusion Care at Home

Subcutaneous infusion may be used for selected medicines or fluids when an authorised plan specifies the product, route, rate, volume, site options and monitoring. Absorption depends on tissue condition and circulation, so the nurse assesses pain, redness, swelling, leakage, firmness and device position as well as symptom control. A syringe driver or pump reading does not prove that the intended dose reached suitable tissue.

A home nurse prepares carefully for an assessed clinical visit with a Malaysian family
Direct answer

Subcutaneous Infusion Care at Home

Confirm the current prescription, medicine preparation, concentration, total volume, rate, device programme, compatible combinations, site restrictions and breakthrough-dose plan. Inspect the site and tubing before starting or continuing. Stop and seek direction for significant pain, spreading redness, marked swelling, leakage, bleeding, dislodgement, repeated alarms, unexpected sedation or poor symptom control. Severe breathing difficulty, collapse or a rapidly progressing reaction requires emergency help.

Who this guide is for

  • Adults with a prescribed syringe-driver or intermittent subcutaneous plan
  • Families supporting palliative or symptom-control care
  • Coordinators preparing medicine, pump and replacement supplies

Follow both the medicine and the tissue response

Record the indication, medicine names and amounts, diluent, concentration, total volume, delivery period, device and programme, start time, expected finish, site and cannula type. Check allergies, previous site problems, oedema, fragile skin, circulation and areas excluded by the responsible service before selecting a location.

At each observation compare remaining volume and pump history with elapsed time, then trace the tubing, connections and insertion device. Assess local tissue and the intended clinical effect: pain, nausea, agitation, secretions, hydration or another prescribed outcome. Document additional doses separately so the team can distinguish continuous delivery from breakthrough treatment.

  • Complete prescription and device record
  • Site chosen for tissue condition
  • Volume, time and tubing reconciliation
  • Symptom response and extra-dose log

Choose and rotate a site for absorption, comfort and observation

Use only sites permitted in the current plan, considering oedema, poor circulation, fragile or irradiated skin, infection, pressure, movement and preferred positions. Record the exact site and rotation history so replacement does not return to compromised tissue.

Compare pain, redness, warmth, firmness, swelling, leakage and bleeding with rate, volume, medicine mixture, cannula position and symptom response. Replace or escalate under protocol; do not massage swelling or raise the rate to overcome delayed absorption.

    Treat pump status and symptom control as separate evidence

    At handover, reconcile the medicine label, syringe or reservoir volume, device programme, start time, expected finish and breakthrough doses. Trace the tubing and inspect the actual site. A running display does not confirm delivery into suitable tissue or symptom control.

    Seek direction for repeated alarms, unexpected volume, damage, disconnection, significant swelling or pain, leakage, bleeding, increasing drowsiness, agitation or uncontrolled symptoms. Severe breathing difficulty, collapse, facial swelling or a fast reaction needs emergency help. Never reprogramme or combine medicines without authorisation.

      Primary sources

      Sources support general principles; the individual treating team’s instructions take priority.

      What matters before arranging a visit

      What matters before arranging a visit

      Support that may be relevant

      • Match the prepared medicine to the live order
      • Choose and assess the site within the written plan
      • Trace tubing and check actual pump status
      • Review symptom control and adverse effects together

      How a home visit is planned

      • List permitted sites and rotation criteria
      • Define alarm, interruption and replacement actions
      • Clarify who may prepare or change the medicine container
      • Keep breakthrough doses separate and fully recorded

      Ask about subcutaneous infusion care at home

      The WhatsApp message mentions this page and leaves space for your city or suburb. The provider must confirm suitability, scope, timing and fees before any visit.

      Ask on WhatsApp

      Safety boundaries and escalation

      • Do not massage a swollen infusion site or increase the rate to compensate
      • Do not combine medicines without an authorised compatibility check
      • Do not hide pump alarms or tubing beneath bedding where they cannot be observed

      This website is not an emergency service. Call 999 if someone has severe breathing difficulty, chest pain, heavy bleeding, sudden weakness, loss of consciousness or rapid deterioration.

      FAQ

      Questions families often ask

      Does a small lump always mean the infusion failed?

      Not always, but swelling, firmness, pain, leakage and symptom control must be assessed together under the site protocol.

      Updated: 29 July 2026 • Sources and clinical instructions must be confirmed for each case.

      Ask on WhatsApp